Literature DB >> 33546079

Hypertrophic spinal pachymeningitis caused by ANCA-associated vasculitis revealed by 18F-FDG PET/CT: A case report.

Meiqi Wu1,2, Jingyun Ren1,2, Yaping Luo1,2.   

Abstract

RATIONALE: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) can involve the central nervous system in estimatedly 15% of patients. Hypertrophic pachymeningitis causes inflammatory hypertrophy of the cranial or spinal dura mater and patients present with various neurological deficits. ANCA-associated hypertrophic spinal pachymeningitis has rarely been reported in literature. We report a case of AAV presenting with hypertrophic spinal pachymeningitis detected by 18F-FDG PET/CT. PATIENT CONCERNS: A 66-year-old woman diagnosed with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis developed back pain, bilateral lower limb weakness, dysuria, and dysporia 1 month ago. DIAGNOSIS: Contrast-enhanced MRI showed thickening and enhancement of the dura mater in the thoracic cord. Intraspinal hypermetabolism in the corresponding region was observed on 18F-FDG PET/CT. The patient was finally diagnosed with ANCA-associated hypertrophic spinal pachymeningitis.
INTERVENTIONS: The patient was treated with a higher dose of prednisone and cyclophosphamide. OUTCOMES: After 2-week treatment, the patient's neurological symptoms improved rapidly and laboratory findings were ameliorated. A repeated contrast-enhanced MRI showed partial improvement of the disease in the thoracic cord. LESSONS: 18F-FDG PET/CT and contrast-enhanced MRI can aid in the clinical diagnosis and surveillance in AAV-associated hypertrophic spinal pachymeningitis and potentially facilitate early recognition and intervention to prevent irreversible neurological impairment.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33546079      PMCID: PMC7837913          DOI: 10.1097/MD.0000000000024388

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  35 in total

1.  May 2001: 32 year old female with dural mass encircling cervical spinal cord.

Authors:  P J McCarthy; W P Arend; B K Kleinschmidt-DeMasters
Journal:  Brain Pathol       Date:  2001-10       Impact factor: 6.508

2.  Exceptional osseous and meningeal spinal localization of ANCA-associated granulomatous vasculitis with hypertrophic spinal pachymeningitis.

Authors:  Cecile Durant; Jérome Martin; Pascal Godmer; Anne Moreau; Agathe Masseau; Mohamed Hamidou
Journal:  J Neurol       Date:  2011-01-06       Impact factor: 4.849

3.  Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients.

Authors:  T Sakairi; N Sakurai; M Nakasatomi; H Ikeuchi; Y Kaneko; A Maeshima; Y Nojima; K Hiromura
Journal:  Scand J Rheumatol       Date:  2018-11-05       Impact factor: 3.641

4.  FDG PET in Diffuse Spinal Carcinomatous Meningitis.

Authors:  Cécile Cuvilliers; Flora Ahrweiller; Elodie Vauléon; Joël Castelli; Xavier Palard-Novello
Journal:  Clin Nucl Med       Date:  2019-06       Impact factor: 7.794

5.  A nationwide survey of hypertrophic pachymeningitis in Japan.

Authors:  Tomomi Yonekawa; Hiroyuki Murai; Satoshi Utsuki; Takuya Matsushita; Katsuhisa Masaki; Noriko Isobe; Ryo Yamasaki; Mari Yoshida; Susumu Kusunoki; Kiyomi Sakata; Kiyotaka Fujii; Jun-ichi Kira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-22       Impact factor: 10.154

6.  Pachymeningitis as a manifestation of ANCA-associated vasculitis: a care report and literature review.

Authors:  Sheyu Li; Honghu Tang; Xia Rong; Xiangyang Huang; Qianrui Li
Journal:  Int J Clin Exp Med       Date:  2015-04-15

7.  Cerebrospinal fluid cytokine/chemokine/growth factor profiles in idiopathic hypertrophic pachymeningitis.

Authors:  Xu Zhang; Takayuki Fujii; Hidenori Ogata; Ryo Yamasaki; Katsuhisa Masaki; Yiwen Cui; Takuya Matsushita; Noriko Isobe; Jun-Ichi Kira
Journal:  J Neuroimmunol       Date:  2019-02-13       Impact factor: 3.478

8.  Spinal IgG4-Related Hypertrophic Pachymeningitis with Spinal Cord Compression: Case Report and Literature Review.

Authors:  Stephen J Slade; Erin M Bauer; Vivian V Stone; Amish J Dave
Journal:  World Neurosurg       Date:  2019-06-27       Impact factor: 2.104

9.  Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma.

Authors:  Rosa Fonti; Barbara Salvatore; Amalia De Renzo; Emanuele Nicolai; Silvana Del Vecchio
Journal:  Clin Nucl Med       Date:  2016-02       Impact factor: 7.794

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more
  1 in total

1.  Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS).

Authors:  Yasuhiro Shimojima; Dai Kishida; Takanori Ichikawa; Takashi Kida; Nobuyuki Yajima; Satoshi Omura; Daiki Nakagomi; Yoshiyuki Abe; Masatoshi Kadoya; Naoho Takizawa; Atsushi Nomura; Yuji Kukida; Naoya Kondo; Yasuhiko Yamano; Takuya Yanagida; Koji Endo; Shintaro Hirata; Kiyoshi Matsui; Tohru Takeuchi; Kunihiro Ichinose; Masaru Kato; Ryo Yanai; Yusuke Matsuo; Ryo Nishioka; Ryota Okazaki; Tomoaki Takata; Takafumi Ito; Mayuko Moriyama; Ayuko Takatani; Yoshia Miyawaki; Toshiko Ito-Ihara; Takashi Kawaguchi; Yutaka Kawahito; Yoshiki Sekijima
Journal:  Arthritis Res Ther       Date:  2022-08-23       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.